Telbivudine therapy may shape CD4+ T‐cell response to prevent liver fibrosis in patients with chronic hepatitis B

E-ISSN： 1478-3231|35|3|834-845

ISSN： 1478-3223

Source： LIVER INTERNATIONAL (ELECTRONIC), Vol.35, Iss.3, 2015-03, pp. : 834-845

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Effects of antiviral therapy with Telbivudine on peripheral iNKT cells in HBeAg(+) chronic hepatitis B patients

By Shi T.

Clinical and Experimental Medicine, Vol. 12, Iss. 2, 2012-06 ,pp. : 105-113

Springer Publishing Company

Access to resources Recommend Favorite

CD4+/CD45RA+ ‘Naive' T Cells and Immunological Response to Influenza Virus Vaccine in B-Cell Chronic Lymphocytic Leukaemia Patients

Acta Haematologica, Vol. 99, Iss. 1, 1998-01 ,pp. : 18-21

Karger

Access to resources Recommend Favorite

Cell adhesion molecules and hyaluronic acid as markers of inflammation, fibrosis and response to antiviral therapy in chronic hepatitis C patients

By Grano Esther Shouval Daniel Ashur Yaffa

Mediators of Inflammation, Vol. 10, Iss. 5, 2001-10 ,pp. : 253-258

Informa Healthcare

Access to resources Recommend Favorite

B cells expressing CD11b effectively inhibit CD4+ T‐cell responses and ameliorate experimental autoimmune hepatitis in mice

HEPATOLOGY, Vol. 62, Iss. 5, 2015-11 ,pp. : 1563-1575

John Wiley & Sons Inc

Access to resources Recommend Favorite

Analysis of T Cell Receptor Variable Regions and Complementarity Determining Region 3 of Infiltrating T Lymphocytes in the Liver of Patients with Chronic Type B Hepatitis

Intervirology, Vol. 46, Iss. 5, 2003-10 ,pp. : 277-288

Karger

Access to resources Recommend Favorite